Researcher defends statins for primary CAD prevention in women

11/18/2013 | Medscape (free registration)

Dr. Noel Bairey Merz of Cedars Sinai Medical Center in Los Angeles told the American Heart Association meeting that women who do not have cardiovascular disease should still get statin medications if their baseline risk supports using primary prevention. Merz discounted studies that did not show clear evidence of preventive efficacy, saying they were not designed to test statin drugs only in women. "So should we withhold treatment for women, who now are the majority of victims of cardiovascular disease, because of low precision and a trial that was not designed to address or answer this question?" she asked.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ